Feb. 28, 2014 13:00 UTC

Research and Markets: PharmaPoint: Hemophilia A and B - France Drug Forecast and Market Analysis to 2022 Report

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/4z2vb2/pharmapoint) has announced the addition of the "PharmaPoint: Hemophilia A and B - France Drug Forecast and Market Analysis to 2022" report to their offering.

The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood.

However, the burden on patients and their families to maintain the prophylactic treatment schedule is high, and there is a significant unmet need for new therapies that can reduce the number of weekly prophylactic infusions and alleviate some of this treatment burden.

The authors primary research indicates that the high annual cost of therapy in France is of great concern among French physicians and regulators and therefore the opportunities for premium pricing for new therapies will be limited during the forecast period. The authors believe that the clinical benefits offered by the emerging long-acting replacement factors will be sufficient to allow companies to negotiate modest price premiums for the long-acting therapies.

Scope

- Overview of Hemophilia A and B including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on the key drugs in France including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for the top drugs in France from 2012-2022.

- Analysis of the impact of key events as well the drivers and restraints affecting France Hemophilia A and B market.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Disease Overview

Disease Management

Competitive Assessment

Opportunity and Unmet Need

Pipeline Assessment

Market Outlook

Appendix

List of Tables

List of Figures

For more information visit http://www.researchandmarkets.com/research/4z2vb2/pharmapoint

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Source: Research and Markets